Corneal Collagen Cross-Linking (CXL) in El Paso

What Is Corneal Collagen Cross-Linking?

Corneal collagen cross-linking (often referred to simply as CXL) is a minimally invasive, outpatient treatment designed to strengthen a weakened cornea. The procedure involves applying riboflavin (Vitamin B2) eye drops to the cornea and then shining a controlled ultraviolet (UV) light on the eye. This causes a chemical reaction that creates new “cross-links” or bonds between collagen fibers in the cornea, essentially adding support beams to the corneal structure. By increasing collagen cross-links, CXL makes the cornea stiffer and more stable, which helps it maintain its proper shape and structure.

View Video

Treating Progressive Corneal Conditions

CXL is primarily performed to treat keratoconus and corneal ectasia, a condition that can occur after refractive surgeries such as LASIK. Keratoconus typically begins in the teenage years or early 20s, when the cornea gradually thins and bulges forward into a cone shape. This abnormal shape prevents light from focusing properly, leading to blurry or distorted vision, glare, and frequent changes in eyeglass or contact lens prescriptions. If left untreated, keratoconus often worsens over time, and about 1 in 5 patients may eventually require a corneal transplant due to severe thinning or scarring. Corneal ectasia follows a similar pattern of instability and bulging after surgery.

Diagram comparing a healthy eye, a keratoconus eye, and an eye with corneal ectasia, showing normal corneal shape versus corneal thinning and forward bulging.

Couple holding their grandbaby, representing preserved vision and long-term eye health after corneal cross-linking treatment.

Stopping Progression and Preserving Vision

Corneal cross-linking is performed to halt the progression of these conditions. By strengthening and stiffening the corneal tissue, CXL helps the cornea resist further thinning or bulging. The primary goal is not to immediately improve vision, but to preserve your current level of sight and prevent further loss. For this reason, doctors often recommend CXL as soon as there is evidence that keratoconus or ectasia is progressing. Treating the condition early can protect long-term vision and significantly reduce the likelihood of needing a corneal transplant in the future. After CXL, many patients can still use glasses or contact lenses to correct remaining blur, but without treatment, the disease may progress beyond what lenses can manage.

Benefits of Corneal Cross-Linking

Corneal cross-linking offers several important benefits for patients with progressive keratoconus or ectasia:

Halts Disease Progression

The primary benefit is that CXL can prevent keratoconus and ectasia from worsening. This helps preserve your current vision. Traditional treatments, such as contact lenses, can only manage symptoms, but CXL addresses the root cause by strengthening the cornea.

Prevents Vision Loss

By stabilizing the cornea early, cross-linking significantly reduces the risk of severe corneal damage and scarring, which can cause permanent vision loss. Many patients who undergo CXL avoid needing a corneal transplant in the future, which is a much more invasive procedure.

Minimally Invasive & Outpatient

CXL is done in the office with eye-drop anesthesia; no injections or stitches are required, and no hospital stay. The treatment is relatively quick (about an hour), and you go home the same day.

Long-Term Stability

Cross-linking creates lasting changes in the cornea’s biomechanical strength. Studies show that once the cornea is cross-linked, the stability is long-term in the majority of patients. This means the benefits of a single treatment can persist for years, effectively freezing the disease’s progression.

Possible Vision Improvement

While the primary goal is to stabilize, some patients do notice a modest improvement in vision over time. As the cornea’s shape becomes more regular (less cone-shaped), glasses or contacts correct vision more effectively, and things may appear clearer than before. CXL can also improve tolerance for contact lenses. A stronger cornea often feels more comfortable with lenses and can handle them longer each day

The primary benefit is that CXL can prevent keratoconus and ectasia from worsening. This helps preserve your current vision. Traditional treatments, such as contact lenses, can only manage symptoms, but CXL addresses the root cause by strengthening the cornea.

By stabilizing the cornea early, cross-linking significantly reduces the risk of severe corneal damage and scarring, which can cause permanent vision loss. Many patients who undergo CXL avoid needing a corneal transplant in the future, which is a much more invasive procedure.

CXL is done in the office with eye-drop anesthesia; no injections or stitches are required, and no hospital stay. The treatment is relatively quick (about an hour), and you go home the same day.

Cross-linking creates lasting changes in the cornea’s biomechanical strength. Studies show that once the cornea is cross-linked, the stability is long-term in the majority of patients. This means the benefits of a single treatment can persist for years, effectively freezing the disease’s progression.

While the primary goal is to stabilize, some patients do notice a modest improvement in vision over time. As the cornea’s shape becomes more regular (less cone-shaped), glasses or contacts correct vision more effectively, and things may appear clearer than before. CXL can also improve tolerance for contact lenses. A stronger cornea often feels more comfortable with lenses and can handle them longer each day

Who Is a Good Candidate for CXL?

Corneal cross-linking is recommended for people with progressive corneal thinning conditions, primarily keratoconus. You might be a good candidate for CXL if:

1

Progression is documented.

You have keratoconus or corneal ectasia and testing shows worsening changes.

2

You are early in the disease stage.

Patients in their teens, 20s, or 30s with early to moderate keratoconus tend to benefit most, especially before scarring or severe thinning develops.

3

Your cornea is thick enough for treatment.

Corneal thickness is carefully measured during your exam. Very thin corneas may not qualify for CXL.

4

Your overall eye health is good.

Active infections or surface conditions must be treated first.

5

Your goal is vision preservation.

Corneal cross-linking is a preventative treatment. Treating early can help protect long-term vision.

How Does the CXL Procedure Work?

Corneal cross-linking works through a combination of vitamin eye drops and exposure to light. The ophthalmologist first applies special riboflavin (vitamin B2) eye drops onto the cornea. Riboflavin is a photosensitizing vitamin, meaning it reacts when exposed to a certain type of light. After the cornea is saturated with these drops, a controlled ultraviolet-A (UVA) light is shone directly onto the eye for a specified period (about 30 minutes in the standard protocol). The UV light activates the riboflavin, which leads to the formation of new bonds between the collagen fibers in the cornea.

Think of it like curing glue with a UV lamp – the cornea’s collagen essentially “glues” together more tightly. These new collagen bonds (or cross-links) cause the cornea to become stiffer and stronger. In technical terms, the collagen fibers shorten and thicken, reinforcing the cornea’s structure. Importantly, this extra rigidity helps the cornea maintain its proper shape and prevents it from bulging further. The end result is a cornea that’s more stable and resistant to the progression of keratoconus or ectasia.

Epi-Off vs. Epi-On

At Southwest Eye Institute (as in most U.S. clinics), we perform the FDA-approved “epi-off” CXL method. Epi-off means the thin outer layer of the cornea (the epithelium) is gently removed at the start of the procedure. Removing this layer enables the riboflavin eye drops to penetrate deeply into the cornea, providing effective treatment. After UV light treatment, the epithelium will regrow over the next few days as the eye heals. The epi-off technique has an excellent success rate (over 95% effectiveness in halting keratoconus progression according to clinical studies). There are “epi-on” methods (leaving the epithelium intact) being researched, but those are not yet FDA-approved and have more variable results. Rest assured, the protocol we use is proven, safe, and covered by most insurance plans.

Risks and Side Effects

Corneal cross-linking is generally considered safe, especially when performed according to the approved protocol by experienced surgeons. However, like any medical procedure, it carries some risks and potential side effects:

Short-Term Discomfort

Almost every patient experiences eye pain or discomfort in the first few days after CXL. Expect light sensitivity, tearing, redness, and a gritty sensation while the cornea surface heals. This condition is temporary and can be managed with medications and protective lenses.

Infection

There is a small risk of corneal infection whenever the epithelium is removed. We minimize this risk by performing the procedure in a sterile environment and prescribing antibiotic drops. Infection after CXL is rare, but if it occurs, it needs prompt treatment to prevent scarring.

Corneal Haze or Scarring

Some patients develop a faint haze in the cornea as it heals. In most cases, this haze is minor and fades over time. Significant scarring or persistent haze are uncommon, but if they occur, they could affect vision. Following post-op instructions (like using steroid drops and avoiding eye rubbing) helps ensure proper healing of the cornea’s surface to minimize this risk.

Vision Changes

It is normal to have blurred vision for days or weeks after CXL. In rare cases, a patient’s vision could end up slightly worse than before due to scar tissue or irregular healing. It’s essential to understand that CXL does not typically improve vision on its own, so managing expectations is crucial – the primary benefit is preventing further vision loss. Any residual refractive issues can usually be corrected with glasses or contacts once the eye has healed.

Serious Complications

Very rare complications include prolonged corneal swelling, sterile inflammation, or corneal ulcer. These occur in only a tiny fraction of cases. Overall, corneal cross-linking has a low complication rate when proper protocols are followed. At Southwest Eye Institute, patient safety is our top priority – we will only recommend CXL if we believe the potential benefits outweigh the risks in your situation. We also closely monitor you after the procedure to identify and treat any issues promptly.